Home/ Supplements/ Omega 3/ CitraNatal DHA Gelatin Capsule

CitraNatal DHA Gelatin Capsule

product on market Capsule Mission Pharmacal CitraNatal Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) are omega-3 fatty acids that support fetal brain and visual development. There is strong evidence supporting the role of these nutrients in neonatal neurological health. This ingredient profile is associated with a high safety rating.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for CitraNatal DHA Gelatin Capsule
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Gelatin Capsule(s)
Serving Size
Fat/Fatty Acid
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)

Other Ingredients

high Oleic Sunflower Oil Sunflower Lecithin Rosemary extract Tocopherols Ascorbyl Palmitate
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Info

Product Information

Directions for Use

DOSAGE AND ADMINISTRATION: One tablet and one capsule daily or as directed by a physician.

Warnings & Precautions

CONTRAINDICATIONS: This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

WARNING: Ingestion of more than 3 grams of omega-3 fatty acids per day has been shown to have potential antithrombotic effects, including an increased bleeding time and INR. Administration of omega-3 fatty acids should be avoided in patients on anticoagulants and in those known to have an inherited or acquired bleeding diathesis.

Formulation Notes

Rx Prenatal Vitamin Tablet and 250 mg DHA Capsule

- Natural, plant-based DHA for your baby's healthy development

- Gluten and lactose free

An Rx prenatal vitamin and omega-3 (DHA) derived from an all natural plant source

DESCRIPTION: CitraNatal(R) DHA is a prescription prenatal/postnatal multivitamin/mineral tablet with Ferr-Ease(R), a patented dual-iron delivery comprising both a quick release and slow release iron, and a capsule of an essential fatty acid.

INDICATIONS: CitraNatal(R) DHA is a multivitamin/mineral prescription drug indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and non-lactating mothers.

Additional Information

HOW SUPPLIED: Six child-resistant blister packs of 5 tablets and 5 capsules each - NDC 0178-0829-30

500238 C01 Rev 011110

Mission PHARMACAL(R)

March of Dimes does not endorse specific products or brands.

Child-Resistant Blister Packaging

N

#1 RX prenatal vitamin brand

Rx Only

NDC 0178-0898-30

life'sDHA(TM) HEALTHY BRAIN, EYES, HEART

march of dimes(R)

CONTAINS Six 5-day Blister Packs

The essential fatty acid DHA capsule is caramel colored and contains a light yellow to orange semi-solid mixture.

STORAGE: Store at 20-25(0)C (68-77(0)F)

Gentle nutrition for baby and mom

Metadata

Product Details

UPC / SKU6 89076 89830 7
DSLD Entry Date2015-05-22
Product TypeFat/Fatty Acid
FormCapsule
DSLD ID45465
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.